Jeronselvain Unveils PDRN-Based Oral Care Product "Eatoncare" as It Expands in the Oral Market View original image

Jeronselvain, a company specializing in the production of pharmaceutical products, is expanding its oral care product lineup. On April 20, the company announced the launch of its new product “Eatoncare,” which utilizes polydeoxyribonucleotide (PDRN).


This new product was developed based on Jeronselvain’s patented “Prism Technology Nano PDRN.” The technology applies high-purity PDRN raw material of small and uniform particle size, and the company plans to seek new growth opportunities in the oral care market based on this innovation.


The product development process reflects the company’s accumulated research experience in the dental field. Jeronselvain designed the product by applying the concept of “oral balance conditioning” to address both sensitive oral environments and everyday care needs.


In particular, through joint development with the Seoul National University Dental Association, the product was tailored for use even after changes in oral condition following dental treatment. It is specifically designed to be suitable for daily use, even in sensitive oral environments.


“Eatoncare Oral PDRN” adopts a stepwise approach to managing oral conditions. The PDRN ingredient promotes the creation of an environment conducive to recovery, while trehalose helps stabilize the environment by protecting cell membranes and proteins. The product also includes oral probiotics to help maintain microbial balance.


Additionally, instead of a single strain, a combination of multiple strains was used to address four key functions: stabilization of the oral environment, improvement of gum and mucosal condition, mucosal stability, and balancing of sensitive environments. According to the company, this approach enables oral care based on the microbiome.


Deokkyu Kim, CEO of Jeronselvain, stated, “This product began with the idea of providing a method for consistent oral care even after dental treatments,” adding, “It is the result of expanding our specialized research achievements into everyday care routines.”



He continued, “As the oral care market is increasingly shifting toward functionality and premium products, we will use this new product to expand our reach beyond pre- and post-dental treatment care to the broader market for everyday oral condition management.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing